LTS LOHMANN Therapie-Systeme AG Acquires Tapemark Inc.

August 22, 2022

LTS LOHMANN Therapie-Systeme AG (LTS) has completed the acquisition of Tapemark Inc., a U.S.-based CDMO specializing in transdermal drug delivery systems and oral thin films. The deal integrates Tapemark’s St. Paul (West St. Paul), Minnesota facility into LTS’s global network to strengthen LTS’s U.S. footprint, expand manufacturing capacity and R&D capabilities, and broaden its drug-delivery technology portfolio.

Buyers
LTS LOHMANN Therapie-Systeme AG
Targets
Tapemark Inc.
Industry
Pharmaceuticals
Location
Minnesota, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.